Arcellx Inc

ACLX · NASDAQ

Research and Development in Biotechnology · US

Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.

Market Data

Price $115.07 +0.04 (+0.03%)

Market Cap$6.73B

P/E Ratio—

EPS$—

52W High$115.13

52W Low$47.86

Beta0.17

Data from Finnhub · Updated May 1, 2026